Great. Good afternoon, everyone. I'm Ellie Merle, one of the biotech analysts here at Barclays. Very happy to have Ionis here with us today for a fireside chat, but we should call it a beachside chat ...

Agfa-Gevaert Group in 2025: strong Q4 profitability and free cash flow - good step-up in FY profitability in HealthCare IT and Digital Print & Chemicals Group performance: Strong Q4 adjusted EBITDA of ...